Metabolic Disease
CIR Biopharma's in vivo pharmacodynamics team has rich experience in constructing animal models of metabolic diseases and in vivo pharmacology research, and has constructed a variety of metabolic disease models. To meet the differentiated needs of customers, the team can provide customized services to develop suitable animal models and appropriate in vivo pharmacodynamic study for our customers.
Osteoporosis model
Osteoporosis model of castrated female rat
Glucocorticoid-induced osteoporosis model in rats
Retinoic acid A induced osteoporosis model in rats
Cholestasis model
Bile duct ligation cholestasis model in rats
DDC-induced cholestasis model in mice
Diabetes model
ZDF rat diabetes model
db/db mouse diabetes model
ob/ob mouse diabetes model
Liver disease model
Non-alcoholic steatohepatitis（NASH）mouse model
TAA-induced mouse liver fibrosis model